相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel therapeutic targets for cholestatic and fatty liver disease
Michael Trauner et al.
GUT (2022)
Drug Therapies for Chronic Cholestatic Liver Diseases
Martin Wagner et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
A novel non-bile acid FXR agonist EDP-305 potently suppresses liver injury and fibrosis without worsening of ductular reaction
Ping An et al.
LIVER INTERNATIONAL (2020)
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances
Keisaku Sato et al.
HEPATOLOGY (2019)
Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis
Runping Liu et al.
HEPATOLOGY (2019)
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
Raquel T. Yokoda et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis
Guangying Cui et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis
Dai-Min Xiang et al.
GUT (2018)
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kris V. Kowdley et al.
HEPATOLOGY (2018)
Long-Term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis
Sumeyye Samur et al.
HEPATOLOGY (2017)
Steroidal or non-steroidal FXR agonists - Is that the question?
Len Verbeke et al.
JOURNAL OF HEPATOLOGY (2017)
Management of cholestatic disease in 2017
Elsemieke de Vries et al.
LIVER INTERNATIONAL (2017)
Integrin alpha v beta 6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis
Zhen-Wei Peng et al.
HEPATOLOGY (2016)
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-1 biliary secretion in mice
Nan Wu et al.
HEPATOLOGY (2016)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β-Catenin in Mice
Yingying Liu et al.
STEM CELLS (2015)
Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice
J. D. Coombes et al.
GUT (2015)
Galectin-3 regulates hepatic progenitor cell expansion during liver injury
Wei-Chen Hsieh et al.
GUT (2015)
Osteopontin induces ductular reaction contributing to liver fibrosis
Xiaodong Wang et al.
GUT (2014)
Osteopontin: Versatile modulator of liver diseases
Sumiko Nagoshi
HEPATOLOGY RESEARCH (2014)
Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury
Maryna Perepelyuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Human and Experimental Evidence Supporting a Role for Osteopontin in Alcoholic Hepatitis
Oriol Morales-Ibanez et al.
HEPATOLOGY (2013)
The TGR5 receptor mediates bile acid-induced itch and analgesia
Farzad Alemi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
Wing-Kin Syn et al.
GUT (2012)
Osteopontin is Induced by Hedgehog Pathway Activation and Promotes Fibrosis Progression in Nonalcoholic Steatohepatitis
Wing-Kin Syn et al.
HEPATOLOGY (2011)
Drug-Induced Cholestasis
Manmeet S. Padda et al.
HEPATOLOGY (2011)
Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases
Toshimitsu Uede
PATHOLOGY INTERNATIONAL (2011)
Epithelial-Mesenchymal Interactions in Biliary Diseases
Luca Fabris et al.
SEMINARS IN LIVER DISEASE (2011)
Gene expression profiles during hepatic stellate cell activation in culture and in vivo
Samuele De Minicis et al.
GASTROENTEROLOGY (2007)
Osteopontin expression in normal and fibrotic liver.: Altered liver healing in. osteopontin-deficient mice
D Lorena et al.
JOURNAL OF HEPATOLOGY (2006)
Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases
HY Diao et al.
IMMUNITY (2004)
Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)
R Agnihotri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
